Literature DB >> 16689748

Effects of older age on fibrin D-dimer, C-reactive protein, and other hemostatic and inflammatory variables in men aged 60-79 years.

A Rumley1, J R Emberson, S G Wannamethee, L Lennon, P H Whincup, G D O Lowe.   

Abstract

BACKGROUND: Previous studies have suggested that several hemostatic and inflammatory variables, which are risk predictors for arterial or venous thrombosis, increase with age. However, there is a lack of data from large population studies for reliable estimates of reference ranges.
OBJECTIVES: To establish reliable reference ranges of hemostatic and inflammatory variables for 5-year age groups in older men and their implications for pathogenesis and diagnosis. PATIENTS AND METHODS: A total of 3861 men aged 60-79 years at the 20 years follow-up of the British Regional Heart Study.
RESULTS: Several variables increased with age. The greatest median increases between 60-64 and 75-79 years age groups were observed for fibrin D-dimer (91%) and C-reactive protein (CRP) (57%). Significant median increases were also observed for von Willebrand factor antigen (23%), tissue plasminogen activator antigen (11%), factor VIII (10%), and fibrinogen (8%). In contrast, levels of classical cardiovascular risk factors neither decreased nor increased substantially with age, with the exception of systolic blood pressure (median increase 10%).
CONCLUSIONS: The exponential increases in risk of arterial and venous thrombotic events in men between age 60 and 79 years (when most such events occur) may be related in part to increasing activation of blood coagulation, fibrinolysis, and inflammation; possibly related to the increasing inflammatory burden of both atherosclerotic and non-vascular disease. These increases also have implications for diagnosis of suspected acute venous thromboembolism (D-dimer), and recently proposed screening for prediction of coronary heart disease risk and detection of occult disease (CRP).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16689748     DOI: 10.1111/j.1538-7836.2006.01889.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  26 in total

Review 1.  Risk factors for venous and arterial thrombosis.

Authors:  Emanuele Previtali; Paolo Bucciarelli; Serena M Passamonti; Ida Martinelli
Journal:  Blood Transfus       Date:  2010-10-25       Impact factor: 3.443

Review 2.  Can haemostatic factors predict atherothrombosis?

Authors:  Gordon Lowe
Journal:  Intern Emerg Med       Date:  2011-02-15       Impact factor: 3.397

3.  Can venous thromboembolism navigate the prevention of cardiovascular complications?

Authors:  Alena Shantsila; Gregory Y H Lip
Journal:  Ann Transl Med       Date:  2015-06

Review 4.  Is there a Link Between Atherothrombosis and Deep Venous Thrombosis?

Authors:  Maria-Cristina Andrei; Aurel Andercou
Journal:  Maedica (Buchar)       Date:  2014-03

5.  High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study.

Authors:  Erin M Hald; Sigrid K Brækkan; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; Jan Brox; John-Bjarne Hansen
Journal:  Haematologica       Date:  2011-04-20       Impact factor: 9.941

6.  Large idiopathic unilateral adrenal hematoma in a young woman.

Authors:  L A Marzano; L Tauchmanova; E Marzano; R Arienzo; R Guarino; G Ciancia; A Porcelli; G Lombardi; R Rossi
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

Review 7.  [Importance of biomarkers in pulmonary embolism].

Authors:  S Kupp; J Pöss
Journal:  Internist (Berl)       Date:  2019-06       Impact factor: 0.743

8.  Inflammation and thrombosis biomarkers and incident frailty in postmenopausal women.

Authors:  Alexander P Reiner; Aaron K Aragaki; Shelly L Gray; Jean Wactawski-Wende; Jane A Cauley; Barbara B Cochrane; Charles L Kooperberg; Nancy F Woods; Andrea Z LaCroix
Journal:  Am J Med       Date:  2009-08-13       Impact factor: 4.965

9.  Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients.

Authors:  Rachel E Tilley; Todd Holscher; Rajesh Belani; Jorge Nieva; Nigel Mackman
Journal:  Thromb Res       Date:  2008-02-11       Impact factor: 3.944

Review 10.  C-reactive protein and cardiovascular disease: weighing the evidence.

Authors:  Gordon D O Lowe; Mark B Pepys
Journal:  Curr Atheroscler Rep       Date:  2006-09       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.